Review



celltrace violet  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc celltrace violet
    Celltrace Violet, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/celltrace+violet/Cell+Proliferation+Tracer+Kit/pm41703302-331-7-9
    Average 93 stars, based on 18 article reviews
    celltrace violet - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Tuning Tissue Ingrowth into Proangiogenic Hydrogels via Dual Modality Degradation.
    Article Snippet: The potential to control the rate of replacement of a biodegradable implant by a tissue would be advantageous.. Here, we demonstrate that tissue invasion can be tuned through the novel approach of overlaying an enzymatically degradable hydrogel with an increasingly hydrolytically degradable environment.. Poly(ethylene glycol) (PEG) hydrogels were formed from varying proportions of PEG-vinyl sulfone and PEG-acrylate (PEG-AC) monomers via a Michael-type addition reaction with a dithiol-containing matrix-metalloproteinase-susceptible peptide cross-linker.

    Article Title: Tigecycline and homoharringtonine synergistically target myeloid leukemia cells by inhibiting mitochondrial translation through mTOR/4EBP1 pathway
    Article Snippet: Antibodies specific to -actin (#8457), Caspase3 (#9664), PARP(poly ADP-ribose polymerase) (#9532), 51 p-Akt (#4060), p-mTOR (#5536), p-Raptor (#9111), p-4EBP1 (#13443), COX(Cyclooxygenase)-1 (#9947) 52 including COX-4 (#4844), p-Rictor (#3806), Ki-67 (#9449) were purchased from CST (Danvers, MA).

    Labeling:

    Article Title: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.
    Article Snippet: Lymph nodes were dissected, passed through a 70-μm cell strainer, and CD4+ T cells were purified via a negative selection magnetic bead kit following the manufacturer’s recommendation (BioLegend, cat. no. 480005). .. T cells were counted and labeled with CellTrace Violet (Cell Signaling, cat. no. 48444). ..

    Pyrolysis Gas Chromatography:

    Article Title: The effect of pre-exercise alkalosis on lactate/pH regulation and mitochondrial respiration following sprint-interval exercise in humans.
    Article Snippet: .. We assayed MCT1 and MCT4 [personal antibodies (Thomas et al., 2005)], CD147 (sc-9757 Santa Cruz), NHE1 (MAB3140 Millipore), NBC (AB3212 Millipore), CAII (sc-25596 Santa Cruz), peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α: 4,259 Cell Signaling Technology), cytochrome c oxidase subunit 4 (COX IV: 4,844 Cell Signaling Technology). ..

    Positron Emission Tomography:

    Article Title: Applications of nuclear-based imaging in gene and cell therapy: probe considerations
    Article Snippet: .. , PET: [ 68 Ga]-DOTATOC, [ 68 Ga]-DOTATATE; SPECT: [ 111 In]-DOTA-BASS, [ 111 In]-DTPA-octreotide; [ 99m Tc]demotate 1, [ 99m Tc]P829, [ 188 Re]P829 , brain, adrenal glands, gastrointestinal tract, kidneys, spleen, tumors (i.e., pituitary, neuroendocrine, SCLC, pancreatic, paraganglioma, medullary thyroid carcinoma, pheochromocytomas) , G protein-coupled receptor; tracers responsible for cell signaling, change in proliferation, and might impair cell function; non-metal octreotide can cross the BBB; some radiotracers already in use in the clinics (i.e., 111 In- and 68 Ga-based). ..

    Single Photon Emission Computed Tomography:

    Article Title: Applications of nuclear-based imaging in gene and cell therapy: probe considerations
    Article Snippet: .. , PET: [ 68 Ga]-DOTATOC, [ 68 Ga]-DOTATATE; SPECT: [ 111 In]-DOTA-BASS, [ 111 In]-DTPA-octreotide; [ 99m Tc]demotate 1, [ 99m Tc]P829, [ 188 Re]P829 , brain, adrenal glands, gastrointestinal tract, kidneys, spleen, tumors (i.e., pituitary, neuroendocrine, SCLC, pancreatic, paraganglioma, medullary thyroid carcinoma, pheochromocytomas) , G protein-coupled receptor; tracers responsible for cell signaling, change in proliferation, and might impair cell function; non-metal octreotide can cross the BBB; some radiotracers already in use in the clinics (i.e., 111 In- and 68 Ga-based). ..

    Cell Function Assay:

    Article Title: Applications of nuclear-based imaging in gene and cell therapy: probe considerations
    Article Snippet: .. , PET: [ 68 Ga]-DOTATOC, [ 68 Ga]-DOTATATE; SPECT: [ 111 In]-DOTA-BASS, [ 111 In]-DTPA-octreotide; [ 99m Tc]demotate 1, [ 99m Tc]P829, [ 188 Re]P829 , brain, adrenal glands, gastrointestinal tract, kidneys, spleen, tumors (i.e., pituitary, neuroendocrine, SCLC, pancreatic, paraganglioma, medullary thyroid carcinoma, pheochromocytomas) , G protein-coupled receptor; tracers responsible for cell signaling, change in proliferation, and might impair cell function; non-metal octreotide can cross the BBB; some radiotracers already in use in the clinics (i.e., 111 In- and 68 Ga-based). ..

    Cell Counting:

    Article Title: Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-γ/TGF-β1/Smad2/3 signalling pathway.
    Article Snippet: Cell lysate was used to measure intracellular GSH with a commercial assay kits (Beyotime, Jiangsu, China) as manufacturer’s instructions. .. The cell proliferation was measured by Cell Counting Kit (CCK)-8 assay and BrdU cell proliferation assay kit (CST, Beverly, MA, USA) according to manufacturer’s protocols. ..

    BrdU Cell Proliferation Assay:

    Article Title: Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-γ/TGF-β1/Smad2/3 signalling pathway.
    Article Snippet: Cell lysate was used to measure intracellular GSH with a commercial assay kits (Beyotime, Jiangsu, China) as manufacturer’s instructions. .. The cell proliferation was measured by Cell Counting Kit (CCK)-8 assay and BrdU cell proliferation assay kit (CST, Beverly, MA, USA) according to manufacturer’s protocols. ..



    Similar Products

    99
    Thermo Fisher celltrace violet in pbs
    Celltrace Violet In Pbs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/celltrace+violet/PBS/pm40903576-760-13-17
    Average 99 stars, based on 1 article reviews
    celltrace violet in pbs - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    86
    Fisher Scientific celltrace violet
    Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with <t>CellTrace</t> Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.
    Celltrace Violet, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/celltrace+violet/celltrace+violet/bio_rxiv__64898__2026__04__28__721204-247-8-14
    Average 86 stars, based on 1 article reviews
    celltrace violet - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc celltrace violet
    Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with <t>CellTrace</t> Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.
    Celltrace Violet, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/celltrace+violet/Cell+Proliferation+Tracer+Kit/pm41703302-331-7-9
    Average 93 stars, based on 1 article reviews
    celltrace violet - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher celltrace violet
    1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by <t>CellTrace</t> Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.
    Celltrace Violet, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/celltrace+violet/celltrace+violet/pmc12263106-61-7-9
    Average 90 stars, based on 1 article reviews
    celltrace violet - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with CellTrace Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.

    Journal: bioRxiv

    Article Title: Potential of HLA-E-targeting diabodies to induce lysis of HIV-1-infected cells by CD8 + T cells

    doi: 10.64898/2026.04.28.721204

    Figure Lengend Snippet: Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with CellTrace Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.

    Article Snippet: For dual-color co-cultures, target cells were stained with CellTrace Violet or CFSE (dilution 1:20,000, FisherScientific, Cat. # C34557 and Cat # C34554) for 15 minutes in PBS at 37°C prior to plating.

    Techniques: Transfection, Expressing, Construct, Staining, Cell Culture, Activation Assay, Flow Cytometry, Single Cell, Co-Culture Assay, Control

    1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by CellTrace Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.

    Journal: ImmunoHorizons

    Article Title: Maturation of thymocytes with a monoclonal TCR under control of Trac promoter elements in the absence of β-selection

    doi: 10.1093/immhor/vlaf035

    Figure Lengend Snippet: 1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by CellTrace Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.

    Article Snippet: Cells were then stained with 1 μM CellTrace Violet (Thermo Fisher Scientific) in PBS for 20 min at 37 °C and subsequently quenched with 4 volumes of 4 °C T cell media.

    Techniques: Functional Assay, In Vitro